Parkinson's Trial Points Toward Treatment Research Innovations
23andMe announced it has enrolled more than 2,000 patients into its Parkinson's Disease "community" since it first started recruiting Parkinson's patients for genetic testing about a month ago. This is a pretty major achievement in terms of patient recruitment--and something 23andMe has achieved by partnering with the Michael J. Fox Foundation and the Parkinson's Institute whose "networks of patients have responded overwhelmingly."
- Bradley Kreit's blog
- Login to post comments
-
So much information, such limited ability to understand it all
As patients or health consumers, we have an ever-increasing abundance of information at our fingertips. The Web is full of resources, from WebMd to Wikipedia to Daily Strength to a host of other sites that may or may not be reliable sources. Even the most savvy of users may find sifting through all this information a challenge. Companies like Navigenics and 23andMe provide complex data about our personal health that certainly requires explanation to be properly understood. As we continue to move toward empowering people to become active participants in their health care, we make the assumption that they will be able to keep up with and synthesize the abundance of information that may be relevant to their health.
- Vivian Distler's blog
- Login to post comments
-
